Patents Assigned to QUANTGENE INC.
  • Methods and compositions for detecting cancer biomarkers in bodily fluids
    Patent number: 10907211
    Abstract: The present invention provides methods, compositions, reaction mixtures, and kits for detecting cancer biomarkers in a bodily fluid from a subject. Also provided are methods for selecting cancer biomarkers for use in detecting one or more types of cancer in a subject.
    Type: Grant
    Filed: February 16, 2017
    Date of Patent: February 2, 2021
    Assignee: QUANTGENE INC.
    Inventor: Johannes Bhakdi